biopharmaceutical company focused on the development of innovative immunotherapies for the treatment of tauopathies.
TauC3 Biologics Limited has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
TauC3 Biologics Limited's investors include Alzheimer's Association, Rainwater Charitable Foundation.
TauC3 Biologics Limited is headquartered in Holborn, United Kingdom.
biopharmaceutical company focused on the development of innovative immunotherapies for the treatment of tauopathies.
TauC3 Biologics Limited is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TauC3 Biologics Limited — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/tauc3-biologics-limited. Accessed September 14, 2026.
VCBacked. (2025). TauC3 Biologics Limited — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/tauc3-biologics-limited
{{cite web |title=TauC3 Biologics Limited — Funding & Investors |url=https://www.vcbacked.co/company/tauc3-biologics-limited |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated